CHANGE IN RATINGS
Activision Blizzard (ATVI Quote) upgraded at Goldman Sachs to Buy from Neutral based on attractive late-2009 game slate and reduced investor focus on music genre fatigue. See potential for positive EPS revisions as Q1 results and E3 show ease concerns. Priec target raised to $14 from $10. Bristol-Myers Squibb (BMY Quote) downgraded at Goldman Sachs to Neutral from Buy based on relative valuation and lower potential as a takeout candidate. See greater opportunity in other stocks within coverage universe. Price target trimmed to $23 from $25.
- Loading Comments...
- Loading Comments...
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,270.47 | 1,093.48 | 2,167.88 | 34.29 |
Oil *
75.55
|
|
UP
73.00
|
UP
6.24
|
UP
18.86
|
DOWN
0.17
|
10 Yr
3.43%
SPDR Gold
109.74
|
|
+0.72%
|
+0.57%
|
+0.88%
|
-0.49%
|
Data delayed 20 minutes |














